drug · Product Intelligence

Quetiapine Fumarate
Pipeline Intelligence

Quetiapine Fumarate: 3 indexed trials, 2 sponsors; 0 linked Orange Book patents and 5 FDA-linked events where matched.

⚗
3Indexed trials
▦
2Sponsors
⌁
0Orange Book patent links
◎
5FDA-linked events

Development evidence

NCT00206102AstraZeneca · schizophreniaPHASE4
NCT00621647AstraZeneca · alzheimersPHASE3
NCT00742638Shanghai Jiao Tong University School of Medicine · bipolar_disorderNA

FDA / patent evidence

Orange Book match found; no listed patent relation was retained for this product match.

Regulatory context

FDA_APPROVALQUETIAPINE FUMARATE · 2018-11-16
FDA_APPROVALQUETIAPINE FUMARATE · 2017-11-29
FDA_APPROVALQUETIAPINE FUMARATE · 2017-05-09
FDA_APPROVALQUETIAPINE FUMARATE · 2012-03-27
FDA_APPROVALQUETIAPINE FUMARATE · 2012-03-27

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.